{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:03:22Z","timestamp":1794258202623,"version":"4.9.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F Hoffmann-La Roche AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.isci.2026.115978","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:01:40Z","timestamp":1779364900000},"page":"115978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting ADAR1 p150 triggers tumor inhibition and antitumor immunity to overcome immunotherapy resistance"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7968-1352","authenticated-orcid":false,"given":"Zhichao(Eric)","family":"Ai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sining","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115978_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.lungcan.2021.02.035","article-title":"Strategies to overcome resistance to immune checkpoint blockade in lung cancer","volume":"154","author":"Attili","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.isci.2026.115978_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115978_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.tig.2022.03.013","article-title":"ADAR1 and its implications in cancer development and treatment","volume":"38","author":"Baker","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.isci.2026.115978_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2024.102195","article-title":"RNA editing and immune control: from mechanism to therapy","volume":"86","author":"Hu","year":"2024","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.isci.2026.115978_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40364-023-00503-7","article-title":"Emerging role of the RNA-editing enzyme ADAR1 in stem cell fate and function","volume":"11","author":"Lu","year":"2023","journal-title":"Biomarker Res."},{"key":"10.1016\/j.isci.2026.115978_bib6","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/s41467-018-07824-4","article-title":"Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells","volume":"9","author":"Gannon","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115978_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1073\/pnas.1017241108","article-title":"RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis","volume":"108","author":"Ward","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.isci.2026.115978_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009513","article-title":"To \u201cZ\u201d or not to \u201cZ\u201d: Z-RNA, self-recognition, and the MDA5 helicase","volume":"17","author":"Herbert","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.isci.2026.115978_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13580-0","article-title":"RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages","volume":"7","author":"Pujantell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115978_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115978_bib11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","article-title":"ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis","volume":"606","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115978_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tcb.2024.06.006","article-title":"ADAR1: from basic mechanisms to inhibitors","volume":"35","author":"Rehwinkel","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.isci.2026.115978_bib13","doi-asserted-by":"crossref","first-page":"e01492","DOI":"10.1128\/mbio.01492-25","article-title":"ADAR1 haploinsufficiency and sustained picornaviral RdRp dsRNA synthesis synergize to dysregulate RNA editing and cause multi-system interferonopathy","volume":"16","author":"Miller","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.115978_bib14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1261\/rna.079509.122","article-title":"Generation of a new Adar1p150\u2212\/\u2212 mouse demonstrates isoform-specific roles in embryonic development and adult homeostasis","volume":"29","author":"Liang","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.isci.2026.115978_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-04896-7","article-title":"ADAR1 mutation causes ZBP1-dependent immunopathology","volume":"607","author":"Hubbard","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115978_bib16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.115978_bib17","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.1038\/s41467-025-63554-4","article-title":"A loss-of-function human ADAR variant activates innate immune response and promotes bowel inflammation","volume":"16","author":"Xu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115978_bib18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41586-022-04974-w","article-title":"ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation","volume":"607","author":"de Reuver","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115978_bib19","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.4049\/jimmunol.0804277","article-title":"Novel reporter mouse reveals constitutive and inflammatory expression of IFN-\u03b2 in vivo","volume":"183","author":"Lienenklaus","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.115978_bib20","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1038\/s41467-023-43633-0","article-title":"Dissecting the basis for differential substrate specificity of ADAR1 and ADAR2","volume":"14","author":"Zambrano-Mila","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115978_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109500","article-title":"ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation","volume":"36","author":"de Reuver","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.115978_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41431-019-0458-6","article-title":"Mendelian disease caused by variants affecting recognition of Z-DNA and Z-RNA by the Z\u03b1 domain of the double-stranded RNA editing enzyme ADAR","volume":"28","author":"Herbert","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.isci.2026.115978_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9315027","article-title":"The interplay between RNA editing regulator ADAR1 and immune environment in colorectal cancer","volume":"2023","author":"Zheng","year":"2023","journal-title":"J. Oncol."},{"key":"10.1016\/j.isci.2026.115978_bib24","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1126\/science.284.5421.1841","article-title":"Crystal structure of the Z\u03b1 domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA","volume":"284","author":"Schwartz","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115978_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/acs.biochem.3c00636","article-title":"Z\u03b1 Domain of ADAR1 Binds to an A-Form-like Nucleic Acid Duplex with Low Micromolar Affinity","volume":"63","author":"Nichols","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2026.115978_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-020-01268-5","article-title":"Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224\/Smad4\/ADAR1 successive regulatory circuit","volume":"19","author":"Ma","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.115978_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116151","article-title":"Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival","volume":"44","author":"\u00c1lvarez-Prado","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.115978_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112038","article-title":"Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2","volume":"42","author":"Adamska","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.115978_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007402","article-title":"Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment","volume":"11","author":"Lin","year":"2023","journal-title":"Journal for immunotherapy of cancer"},{"key":"10.1016\/j.isci.2026.115978_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.stem.2023.01.008","article-title":"Reversal of malignant ADAR1 splice isoform switching with Rebecsinib","volume":"30","author":"Crews","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.isci.2026.115978_bib31","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1158\/1538-7445.AM2024-4484","article-title":"Discovery of a potential first-in-class Za targeted small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy","volume":"84","author":"Goswami","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115978_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116765","article-title":"The anti-cancer drug candidate CBL0137 induced necroptosis via forming left-handed Z-DNA and its binding protein ZBP1 in liver cells","volume":"482","author":"Li","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.isci.2026.115978_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.115978_bib33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41592-019-0610-9","article-title":"Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity","volume":"16","author":"Roth","year":"2019","journal-title":"Nat. Methods"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226013532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226013532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:09:42Z","timestamp":1791839382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226013532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2589004226013532"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115978","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting ADAR1 p150 triggers tumor inhibition and antitumor immunity to overcome immunotherapy resistance","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115978"}}